Scaling Up Retinal Screening in an HIV clinic in Nanning, China to prevent blindness from CMV retinitis Peter Saranchuk, MD TB-HIV Adviser Southern Africa.

Slides:



Advertisements
Similar presentations
Week 5- The Organisation of Health Services Part 2.
Advertisements

Mortality Among a Tuberculosis Outbreak Los Angeles County, 2007–2013 Brian Baker, MD Amit Chitnis, MD MPH Leslie Henry, BSN RN PHN 48th CTCA Educational.
HIV Self-Sampling: Establishing a sustainable service
STD Screening in HIV Clinics: Value and Implications Thomas Farley, MD MPH Tulane University Deborah Cohen, MD MPH RAND Corporation.
Simplification, cost-reduction strategies and examples from the field Teri Roberts Diagnostics Advisor Médecins Sans Frontières, Access Campaign 7th.
The South African Cryptococcal Screening Program: Program update XIX international AIDS Conference Washington United States 24 th July 2012 Dr. Samuel.
ARAVIND EYE CARE SYSTEM Aravind Eye Hospital & Postgraduate Institute of Ophthalmology ARAVIND EYE CARE SYSTEM Aravind Eye Hospital & Postgraduate Institute.
Most deaths among children enrolled in two program settings in Cambodia occur within the first 6 months after enrolment. Early mortality rates were more.
Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.
Spotlight Case Treatment Challenges After Discharge.
Integration of HIV and Non-communicable Disease management into Primary Care in Nairobi, Kenya: Characteristics and Outcomes Jeffrey K. Edwards 1, Helen.
1.03 Healthcare Trends.
Experience on Management of CMV Retinitis Medécins Sans Frontiéres Khin Nyein Chan Medical Coordinator, MSF.
Sustainable eye care in Africa Kate Coleman Consultant eye surgeon Executive chairperson/founder Right to Sight.
Standard of Care for MDR-TB
Cytomegalovirus DR.K.RAJA GHTM CHENNAI
Antiretroviral Treatment Costs in Mexico WHO/UNAIDS Workshop on Strategic Information for Anti-Retroviral Therapy Programmes 30 June to 2 July, 2003 Assessment.
Preliminary findings of a routine PMTCT Option B+ programme in a rural district in Malawi Rebecca M. Coulborn 1, Laura Triviño Duran 1, Carol Metcalf 2,
Approved Products for the Treatment of CMV Retinitis in Immunocompromised Patients William M. Boyd, M.D. Division of Anti-inflammatory, Analgesic, and.
The Canadian Association of Optometrists
OPEN ANGLE GLAUCOMA Frank J. Weinstock, MD, FACS Professor of Ophthalmology- NEOUCOM Canton, Ohio USA.
DRUG-RESISTANT TB in SOUTH AFRICA: Issues & Response _ ______ _____ _ ______ _____ ___ __ __ __ __ __ _______ ___ ________ ___ _______ _________ __ _____.
New Treatment Opportunity: Valganciclovir
REFERENCES 1.Roberts E, Morgan R, King D, Clerkin L. Funduscopy: a forgotten art? Postgrad Med J. 1999; 75: McComiskie JE, Greer RM, Gole GA.
6th International AIDS Society Conference Better Diagnostics Are Needed to Achieve an AIDS-Free Generation UNITAID Satellite Event 18 July 2011 Jimmy Kolker.
The Diabetic Retinopathy Clinical Research Network
Advances and Opportunities to Address Co-Infections: CMV Retinitis and Hepatitis C IAS 2013 Sunday 30 July.
1.03 Healthcare Trends Understand healthcare agencies, finances, and trends Healthcare Trends Technology Epidemiology Geriatric Care Wellness Cost.
Prospective Telemedicine Screening for Diabetics at High Risk for Retinopathy. PI- Jayne S Weiss, MD LSUHSC-NO.
1 FDA Review of NDA Valganciclovir for the Treatment of CMV Retinitis in AIDS Joseph Toerner, MD Medical Officer DAVDP.
Background There is uncertainty regarding the frequency, predictors, and outcomes of IRIS events Prior studies on IRIS have been limited to convenience.
European Association for Vision and Eye Research – Crete, Oct 5-8, 2011 Ranibizumab for the Treatment of Exudative Age-Related Macular Degeneration Associated.
BHIVA Clinical Audit Management of patients who switch therapy; re-audit of patients starting therapy from naïve.
1 Diagnosis of HIV Infection in Children HAIVN Harvard Medical School AIDS Initiatives in Vietnam.
TERSON’S SYNDROME Z. Jamaleddine, S. El Haddad, A. El Quessar Service de Radiologie, Hopital Cheikh Zaid Rabat - Morocco.
Implementation of Thin Layer Agar for Mycobacterium culture in rural Kenya Médecins Sans Frontières.
BHIVA Clinical Audit Management of patients who switch therapy; re-audit of patients starting therapy from naïve.
Community Management of Retinopathy of Prematurity Alex R. Kemper, MD, MPH, MS Sheri Carroll, MD David K. Wallace, MD, MPH November 13, 2007 CM-ROP.
HEPATITIS MOBILE TEAM News Tools of screening viral hepatitis in real life: the french model of care André-Jean REMY (1,2), Hugues WENGER (1), Hakim BOUCKHIRA.
1 Monitoring The Patient on ARV Treatment HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Implementation of Collaborative TB/HIV Activities by ICAP: Success and Challenges Andrea Howard, M.D., M.S. 14 th Core Group Meeting of TB/HIV Working.
Providing Treatment, Restoring Hope Program Updates Dr. Robb Sheneberger, MD University of Maryland School of Medicine Track 1.0 Implementers Meeting Dar.
Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents Human Herpesvirus-8 Slide Set Prepared by the.
1 HIV Clinical Staging HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Washington D.C., USA, July 2012www.aids2012.org Implementing Xpert ® MTB/RIF in Rural Zimbabwe Impact on diagnosis of smear-negative TB and time-
The Diabetic Retinopathy Clinical Research Network Effect of Diabetes Education During Retinal Ophthalmology Visits on Diabetes Control (Protocol M) 11.
RETINOPATHY 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada.
Scale up TB/HIV activities in Asia Pacific 8-9Aug09 1 TB/HIV collaborative activities in Thailand Sriprapa Nateniyom, M.D. TB Bureau, Department of Disease.
H Bygrave L Triviño L Makakole Medecins sans Frontieres Lesotho Scott Hospital Morija TB/HIV Integration Lessons learned from implementation of a TB/HIV.
1 Management, Care for infants who were born from infected mothers HAIVN Harvard Medical School AIDS Initiatives in Vietnam.
THE 6 TH NATIONAL SCIENTIFIC CONFERENCE ON HIV/AIDS Yield and impact of repeated screening for tuberculosis and isoniazid preventive therapy among patients.
TB and HIV integrated services at Martin Preuss Centre in Lilongwe, Malawi : “The Lighthouse Trust initiative” Dr Sam Phiri Executive Director Lighthouse.
The Diabetic Retinopathy Clinical Research Network DRCR.net Prompt PRP vs Ranibizumab+Deferred PRP for PDR Study Jeffrey G. Gross, M.D. – Protocol Chair.
Digital Retinal Imaging for Diabetics in a Family Medicine Residency Patient Centered Medical Home Nick Patel, MD Robert Newman, MD April 25,2010.
Glaucoma Lily T. Im, MD. What is glaucoma?   Glaucoma is a group of diseases that damage the eye’s optic nerve and can result in vision loss and blindness.
Prepared by the AETC National Coordinating Resource Center based on recommendations from the CDC, National Institutes of Health, and HIV Medicine Association/Infectious.
The Diabetic Retinopathy Clinical Research Network
1 Keep it Simple ! Innovate to Create Scalable Impact Creating Healthcare Access Through Product Innovation.
Daniel Meressa, M.D. Global Health Committee St. Peter’s Hospital
1.03 PP3 Healthcare Trends.
Keeler All-Pupil II Indirect Ophthalmoscope
1.03 Healthcare Trends.
1.03 Healthcare Trends.
1.03 Healthcare Trends.
Newly Diagnosed Type 2 Diabetes Mellitus
Management of Immune Reconstitution Inflammatory Syndrome (IRIS)
Surveillance for TB in HIV Care and Treatment Settings (CTS)
1.03 Healthcare Trends.
1.03 Healthcare Trends.
1.03 Healthcare Trends.
Presentation transcript:

Scaling Up Retinal Screening in an HIV clinic in Nanning, China to prevent blindness from CMV retinitis Peter Saranchuk, MD TB-HIV Adviser Southern Africa Medical Unit (SAMU) Operational Centre Brussels (OCB) Médecins Sans Frontières (MSF) Advances and Opportunities to Address CMV retinitis Satellite Symposium IAS Conference 30 June 2013

HIV late presenters 31.8% Of people present for the first time with a CD4 count < 200 cells/µL

CMV: The 3rd most common/serious OI

Prior to Nov 2008 in Nanning Problem: Diagnosis of CMV usually delayed –Retinal screening not done –Diagnosis made only after vision loss had already occurred –Irreversible –Required referral to a secondary hospital

Poor Outcomes (prior to Nov 2008) Of 17 patients assessed in Nov 2008 and found to have active or inactive CMV retinitis: –5 (29%) had bilateral involvement –7/11 eyes (64%) with inactive disease were blind* * <20/400 visual acuity and/or able to count fingers at 10 feet

Solution

Training in retinal examination Over 4 days By an ophthalmologist (D. Heiden) Of HIV clinicians In the use of an indirect ophthalmoscope (IO) address given for follow-up support

Ophthalmoscopy The key to both = use dilating drops Indirect Direct Vs.

After Nov 2008 in Nanning Retinal screening –Performed routinely –In all at-risk patients (e.g. those with CD4<100) –By HIV clinicians –Using an indirect ophthalmoscope –In the HIV clinic

CMV retinitis has a typical pattern

After Nov 2008 Now able to diagnose CMV retinitis: –At the first visit –Within minutes –Inexpensively –At primary HIV care level –More easily than other common, serious OIs!

After Nov 2008 Now able to diagnose CMV retinitis: –At the first visit –Within minutes –Inexpensively –At primary HIV care level –More easily than other common, serious OIs! = A point-of-care diagnostic!

Every HIV clinic should have… A bottle of drops to dilate pupils E.g. Tropicamide

Ophthalmologists still involved Telemedicine – ing of digital retinal images Complicated cases –Immune Recovery Uveitis (I.e. IRIS) –Retinal detachment

After Nov 2008 Routine retinal screening  Earlier diagnosis  Earlier treatment  Improved visual outcomes –E.g. Minority of patients now being diagnosed with CMV retinitis are blind

Subsequent Trainings

Average duration of treatment in Nanning ~4.5 months N.B.: ART needs to be initiated as soon as possible

Usual Treatment: Sticking needles into eyes!

Price of valganciclovir needs to be… <1 dollar per tablet to prevent CMV-related blindness and encourage retinal screening

Conclusions 1.Retinal screening performed routinely prevents CMV-related blindness 2.Can be done by trained HIV clinicians –In resource-limited settings 3.Diagnosis of CMV retinitis then becomes easier than other OIs! 4.Need a treatment which is both convenient and affordable

Acknowledgments Dr. David Heiden Pacific Vision Foundation Seva Foundation Chinese partners –Guangxi CDC –The Fourth Hospital of Nanning

Treatment options in Nanning Intravitreal injections (weekly) –Inexpensive –Barbaric! I.v. ganciclovir (daily) –Expensive –Inpatient vs. outpatient? Oral valganciclovir (VG) –Convenient –Outrageously expensive (~40 USD per tablet)